Latest Breaking News On - Director daniel bradbury - Page 1 : vimarsana.com

Castle Biosciences (NASDAQ:CSTL) Shares Down 4 7%

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]

Derekj maetzoldCastle biosciencesRobertw bairdDaniel bradburyAllspring global investments holdingsChina universal asset management coRiverpark advisorsAssetmark incWuxi apptec coCastle biosciences incGet free reportBiosciences stock downDirector daniel bradburyPark advisorsUniversal asset managementGlobal investments holdings

Olympiad Research LP Buys New Shares in Castle Biosciences, Inc (NASDAQ:CSTL)

Olympiad Research LP Buys New Shares in Castle Biosciences, Inc (NASDAQ:CSTL)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdCastle biosciencesDerekj maetzoldZurcher kantonalbank zurich cantonalbankDaniel bradburyAllspring global investments holdingsCastle biosciences incWuxi apptec coOlympiad researchAssetmark incChina universal asset management coFree reportUniversal asset managementGlobal investments holdingsKantonalbank zurich cantonalbankGet free report

Castle Biosciences, Inc (NASDAQ:CSTL) Director Daniel Bradbury Sells 23,323 Shares of Stock

Castle Biosciences, Inc (NASDAQ:CSTL) Director Daniel Bradbury Sells 23,323 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Daniel bradburyCastle biosciencesRobertw bairdZurcher kantonalbank zurich cantonalbankCastle biosciences incAssetmark incYork mellon corpMillrace asset group incGet free reportDirector daniel bradburyNew york mellon corpKantonalbank zurich cantonalbankMillrace asset groupAsset groupMypath melanomaCastle biosciences daily

Daniel Bradbury Sells 23,323 Shares of Castle Biosciences, Inc (NASDAQ:CSTL) Stock

Daniel Bradbury Sells 23,323 Shares of Castle Biosciences, Inc (NASDAQ:CSTL) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Zurcher kantonalbank zurich cantonalbankRobertw bairdDaniel bradburyCastle biosciencesCastle biosciences incYork mellon corpAssetmark incSecurities exchange commissionMillrace asset group incGet free reportDirector daniel bradburyExchange commissionNew york mellon corpKantonalbank zurich cantonalbankMillrace asset groupAsset group

Insider Selling: Castle Biosciences, Inc (NASDAQ:CSTL) Director Sells 9,152 Shares of Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.45, for a total value of $196,310.40. Following the completion of the sale, the director now directly owns 22,782 shares of […]

United statesCastle biosciencesDaniel bradburySecurities exchange commissionFirst republic investment management incBaird financial group incCastle biosciences company profileTower research capitalPricet rowe associates incAmerican international group incCastle biosciences incGet free reportDirector daniel bradburyExchange commissionInternational groupRepublic investment management